Selectis Health Q2 FY26 returns to profit, posts USD 8.12 million net income; revenue falls 55% to USD 4.73 million
GBCS•GBCS•GBCS•GBCS•Cash was USD 7.7 million; debt declined to USD 17 million from USD 31 million at Dec. 31, 2025.
Operating loss widened to USD 2.1 million; property taxes, insurance and other operating costs dropped 49% to USD 4.13 million.
Gain on sale of assets totaled USD 10.15 million; other income rose to USD 758,230 on state credits from Georgia and Oklahoma.
Selectis Health posted net income of USD 8.12 million, swinging from a net loss a year earlier.
Revenue fell 54.73% to USD 4.73 million, due to sales of four Georgia facilities in January and May 2026.
